0.33
price up icon4.30%   0.0136
after-market 시간 외 거래: .35 0.02 +6.06%
loading

Virpax Pharmaceuticals Inc 주식(VRPX)의 최신 뉴스

pulisher
Dec 19, 2024

Virpax Pharmaceuticals names new board director - Investing.com

Dec 19, 2024
pulisher
Dec 19, 2024

Virpax Pharmaceuticals names new board director By Investing.com - Investing.com UK

Dec 19, 2024
pulisher
Dec 15, 2024

Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) Short Interest Update - Defense World

Dec 15, 2024
pulisher
Dec 14, 2024

Virpax Pharmaceuticals announces board member resignation By Investing.com - Investing.com South Africa

Dec 14, 2024
pulisher
Dec 14, 2024

Virpax Pharmaceuticals announces board member resignation - Investing.com

Dec 14, 2024
pulisher
Dec 07, 2024

Virpax Pharmaceuticals stock hits 52-week low at $0.36 By Investing.com - Investing.com Canada

Dec 07, 2024
pulisher
Dec 06, 2024

Virpax Pharmaceuticals stock hits 52-week low at $0.36 - Investing.com

Dec 06, 2024
pulisher
Dec 04, 2024

Virpax Pharmaceuticals Extends Collaboration with NIH Center for Pain Management Innovation - MSN

Dec 04, 2024
pulisher
Dec 01, 2024

VRPX (Virpax Pharmaceuticals) Enterprise Value : $3.71 Mil (As of Dec. 01, 2024) - GuruFocus.com

Dec 01, 2024
pulisher
Nov 29, 2024

Virpax Pharmaceuticals lowers quorum requirement By Investing.com - Investing.com South Africa

Nov 29, 2024
pulisher
Nov 29, 2024

Virpax Pharmaceuticals lowers quorum requirement - Investing.com India

Nov 29, 2024
pulisher
Nov 29, 2024

Virpax Pharmaceuticals : Amendments to Bylaws Form 8 K - Marketscreener.com

Nov 29, 2024
pulisher
Nov 27, 2024

Virpax Pharmaceuticals Announces Positive Results in Study for Long-Lasting Pain Relief Formulation - MSN

Nov 27, 2024
pulisher
Nov 27, 2024

Virpax Pharmaceuticals regains Nasdaq compliance By Investing.com - Investing.com Nigeria

Nov 27, 2024
pulisher
Nov 27, 2024

Virpax Pharmaceuticals regains Nasdaq compliance - Investing.com India

Nov 27, 2024
pulisher
Nov 24, 2024

Virpax Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 24, 2024
pulisher
Nov 23, 2024

Virpax Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements and Makes Key Appointments - Defense World

Nov 23, 2024
pulisher
Nov 22, 2024

Virpax Pharmaceuticals Strengthens Leadership and Expands Collaborations - TipRanks

Nov 22, 2024
pulisher
Nov 22, 2024

Maxim Group Downgrades Virpax Pharmaceuticals (VRPX) - MSN

Nov 22, 2024
pulisher
Nov 22, 2024

Virpax Announces Positive Results for the Swine Model Dose Range Finding Study for Probudur - Marketscreener.com

Nov 22, 2024
pulisher
Nov 22, 2024

Why Is Virpax Pharmaceuticals Stock Gaining On Friday? - Benzinga

Nov 22, 2024
pulisher
Nov 22, 2024

Virpax Pharmaceuticals extends NIH pain management research By Investing.com - Investing.com Australia

Nov 22, 2024
pulisher
Nov 21, 2024

Virpax Pharma Gets Government Cooperation Deal Extension - Marketscreener.com

Nov 21, 2024
pulisher
Nov 21, 2024

Virpax Pharmaceuticals extends NIH pain management research - Investing.com India

Nov 21, 2024
pulisher
Nov 21, 2024

Virpax Announces Agreement with the U.S. Department of Health and Human Services for the Developmental Extension for NES100 Towards IND for Acute and Chronic Non-Cancer Pain Alternative - The Bakersfield Californian

Nov 21, 2024
pulisher
Nov 21, 2024

Virpax Extends NIH Partnership for Novel Non-Addictive Pain Treatment Technology | VRPX Stock News - StockTitan

Nov 21, 2024
pulisher
Nov 21, 2024

VRPX (Virpax Pharmaceuticals) Debt-to-EBITDA : 0.00 (As of Sep. 2024) - GuruFocus.com

Nov 21, 2024
pulisher
Nov 20, 2024

Virpax Pharmaceuticals appoints new CFO - Investing.com

Nov 20, 2024
pulisher
Nov 20, 2024

Virpax Pharmaceuticals appoints new CFO By Investing.com - Investing.com Canada

Nov 20, 2024
pulisher
Nov 20, 2024

Virpax Pharmaceuticals Announces New Chief Financial Officer - TipRanks

Nov 20, 2024
pulisher
Nov 20, 2024

Virpax Pharmaceuticals, Inc. Appoints Usama Chaudhry as Chief Financial Officer - Marketscreener.com

Nov 20, 2024
pulisher
Nov 18, 2024

Spartan Capital Securities, LLC Serves as Sole Placement Agent in Virpax Pharmaceuticals, Inc.'s $5.0 Million Public Offering - The Manila Times

Nov 18, 2024
pulisher
Nov 18, 2024

Spartan Capital Securities, LLC Serves as Sole Placement - GlobeNewswire

Nov 18, 2024
pulisher
Nov 15, 2024

Virpax Pharmaceuticals Raises $5M to Advance Pain Management Drug Development | VRPX Stock News - StockTitan

Nov 15, 2024
pulisher
Nov 15, 2024

Virpax Pharmaceuticals Inc. (VRPX) Quarterly 10-Q Report - Quartzy

Nov 15, 2024
pulisher
Nov 13, 2024

Virpax Pharmaceuticals Prices of $5.0 Million Public Offering of Common Stock and Pre-Funded Warrants - citybiz

Nov 13, 2024
pulisher
Nov 13, 2024

Virpax Pharmaceuticals prices $5 million stock offering - Investing.com

Nov 13, 2024
pulisher
Nov 13, 2024

Virpax Pharmaceuticals prices $5 million stock offering By Investing.com - Investing.com UK

Nov 13, 2024
pulisher
Nov 13, 2024

Virpax Pharmaceuticals Raises $5M in Public Offering to Advance Pain Management Drug | VRPX Stock News - StockTitan

Nov 13, 2024
pulisher
Nov 05, 2024

Adial Pharma Taps Veteran CFO with $150M+ Fundraising Track Record - StockTitan

Nov 05, 2024
pulisher
Oct 15, 2024

Closing Bell Recap: Virpax Pharmaceuticals Inc (VRPX) Ends at 0.48, Reflecting a 1.06 Upturn - The Dwinnex

Oct 15, 2024
pulisher
Oct 14, 2024

Virpax Pharmaceuticals Inc: Navigating a Turbulent Year, Up -95.58% from 52-Week Low - The InvestChronicle

Oct 14, 2024
pulisher
Oct 11, 2024

VRPX stock touches 52-week low at $0.46 amid market challenges - Investing.com India

Oct 11, 2024
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
자본화:     |  볼륨(24시간):